ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS)
$1e-06 -9.9e-05 (-99%)
Analysed ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS) News Sources
IPO market could see a 'robust' lineup in 2026
08-12-2025
yahoo.com
GitLab stock sinks, Anthropic reportedly planning an IPO
03-12-2025
yahoo.com
Microsoft stock falls on reported AI sales quota cut
03-12-2025
yahoo.com
Alphabet's AI, ADP job data, Macy's & Dollar Tree: 3 Things
03-12-2025
yahoo.com
Amazon releases new AI chip amid industry push to challenge Nvidia's dominance
02-12-2025
yahoo.com
OpenAI CEO Sam Altman declares 'code red' as ChatGPT competition mounts
02-12-2025
yahoo.com
Alphabet rises on Gemini 3, Anthropic unveils Claude Opus 4.5
24-11-2025
yahoo.com
Anthropic launches Claude Opus 4.5 as Google's Gemini 3 gains big backers
24-11-2025
yahoo.com
Musk’s xAI in advanced talks to raise $15 billion at $230 billion valuation, WSJ reports
19-11-2025
yahoo.com
Microsoft, Nvidia team up with Anthropic in rare OpenAI-less deal
18-11-2025
yahoo.com
What is the current price of ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS)?
The current price of ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS) is $1e-06.
ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS) since the previous trading day is $-9.9e-05.
ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS) since the previous trading day is -99%.
What is the most recent average sentiment score for ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS)?
The most recent average sentiment score for ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS) is 57 out of 100.
What is the most recent average sentiment for ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS)?
The most recent sentiment for ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS) is .
SEC-8K** Filing Available For ANTHERA PHARMACEUTICALS INC (ANTH:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.